The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia

NCT00277550 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Constipation and Dyspepsia

Interventions

DRUG: Tegaserod and Placebo

Sponsor

Novartis

Collaborators

[object Object]